ProfileGDS4718 / 201611_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 86% 84% 89% 88% 85% 84% 84% 87% 87% 86% 84% 88% 86% 88% 86% 88% 89% 86% 88% 71% 87% 88% 88% 88% 87% 84% 88% 83% 86% 86% 87% 85% 84% 86% 82% 83% 82% 84% 86% 87% 87% 84% 83% 74% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.6205886
GSM549102patient 115, normal, homogenized [OPG study]8.2539784
GSM549104patient 119, normal, homogenized [OPG study]9.0840289
GSM549108patient 138, normal, homogenized [OPG study]8.7325888
GSM549119patient 077, normal, homogenized [OPG study]8.4398685
GSM549133patient 032, cancer, homogenized [OPG study]8.5200684
GSM549139patient 042, cancer, homogenized [OPG study]8.3118284
GSM549099patient 107, normal, homogenized [OPG study]8.6425887
GSM549109patient 139, normal, homogenized [OPG study]8.710187
GSM549110patient 046, normal, homogenized [OPG study]8.6478486
GSM549114patient 063, normal, homogenized [OPG study]8.5059784
GSM549122patient 082, normal, homogenized [OPG study]8.8263288
GSM549134patient 033, cancer, homogenized [OPG study]8.6420886
GSM549136patient 036, cancer, homogenized [OPG study]8.918588
GSM549140patient 044, cancer, homogenized [OPG study]8.6832686
GSM549111patient 047, normal, homogenized [OPG study]8.9170288
GSM549113patient 057, normal, homogenized [OPG study]9.2391289
GSM549132patient 031, cancer, homogenized [OPG study]8.570286
GSM549137patient 038, cancer, homogenized [OPG study]8.8503588
GSM549142patient 047, cancer, homogenized [OPG study]6.8994371
GSM549100patient 110, normal, homogenized [OPG study]8.6267387
GSM549107patient 135, normal, homogenized [OPG study]8.9412488
GSM549115patient 068, normal, homogenized [OPG study]9.0291788
GSM549116patient 072, normal, homogenized [OPG study]8.9163488
GSM549120patient 078, normal, homogenized [OPG study]8.7411987
GSM549131patient 030, cancer, homogenized [OPG study]8.3862984
GSM549118patient 074, normal, homogenized [OPG study]8.8765288
GSM549129patient 027, cancer, homogenized [OPG study]8.2433283
GSM549123patient 088, normal, homogenized [OPG study]8.6061386
GSM549124patient 006, cancer, homogenized [OPG study]8.4568586
GSM549126patient 015, cancer, homogenized [OPG study]8.6616187
GSM549128patient 025, cancer, homogenized [OPG study]8.5271685
GSM549103patient 117, normal, homogenized [OPG study]8.2474984
GSM549117patient 073, normal, homogenized [OPG study]8.6582986
GSM549138patient 041, cancer, homogenized [OPG study]8.1119682
GSM549141patient 045, cancer, homogenized [OPG study]8.3109283
GSM549130patient 028, cancer, homogenized [OPG study]8.009782
GSM549101patient 111, normal, homogenized [OPG study]8.352184
GSM549105patient 128, normal, homogenized [OPG study]8.620886
GSM549106patient 134, normal, homogenized [OPG study]8.9596787
GSM549112patient 048, normal, homogenized [OPG study]8.7187687
GSM549125patient 011, cancer, homogenized [OPG study]8.3437884
GSM549127patient 024, cancer, homogenized [OPG study]8.2512183
GSM549135patient 035, cancer, homogenized [OPG study]7.3107974